Phase II study of fotemustine in patients with advanced ovarian carcinoma. A trial of the EORTC Gynecological Cancer Group.

M. Aapro,F. V. van Wijk,M. van der Burg,W. W. ten Bokkel Huinink,I. Vergote,J. Guastalla,R. Rosso,A. Kobierska,L. Beex,M. Namer,T. Splinter,J. Vermorken
DOI: https://doi.org/10.1016/S0959-8049(03)00198-9
IF: 10.002
2003-05-01
European Journal of Cancer
Abstract:
What problem does this paper attempt to address?